See more : Sarissa Capital Acquisition Corp. (SRSA) Income Statement Analysis – Financial Results
Complete financial analysis of Virbac SA (VRBCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Virbac SA, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- Magnetic Resources NL (MAUCA.AX) Income Statement Analysis – Financial Results
- Far Eastern New Century Corporation (1402.TW) Income Statement Analysis – Financial Results
- PT Karya Bersama Anugerah Tbk (KBAG.JK) Income Statement Analysis – Financial Results
- Sime Darby Berhad (SIME.KL) Income Statement Analysis – Financial Results
- Måsøval AS (MAS.OL) Income Statement Analysis – Financial Results
Virbac SA (VRBCF)
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.25B | 1.22B | 1.06B | 934.20M | 938.34M | 868.93M | 861.88M | 871.83M | 852.62M | 773.12M | 736.08M | 695.16M | 623.06M | 572.83M | 467.42M | 443.36M | 438.55M | 401.64M | 372.40M | 351.40M | 354.76M | 367.94M |
| Cost of Revenue | 437.30M | 421.19M | 351.11M | 316.64M | 314.81M | 294.29M | 303.44M | 300.15M | 297.85M | 244.61M | 231.42M | 215.50M | 340.80M | 181.78M | 151.54M | 145.05M | 144.75M | 227.06M | 209.61M | 116.18M | 0.00 | 0.00 |
| Gross Profit | 809.60M | 794.99M | 712.85M | 617.56M | 623.54M | 574.64M | 558.44M | 571.68M | 554.77M | 528.51M | 504.66M | 479.66M | 282.26M | 391.05M | 315.88M | 298.31M | 293.80M | 174.57M | 162.79M | 235.22M | 354.76M | 367.94M |
| Gross Profit Ratio | 64.93% | 65.37% | 67.00% | 66.11% | 66.45% | 66.13% | 64.79% | 65.57% | 65.07% | 68.36% | 68.56% | 69.00% | 45.30% | 68.27% | 67.58% | 67.28% | 66.99% | 43.47% | 43.71% | 66.94% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 14.81M | 13.10M | 14.32M | 11.12M | 15.04M | 11.51M | 13.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 203.47M | 158.69M | 173.04M | 0.00 | 179.03M | 181.93M | 208.14M | 164.56M | 158.96M | 158.74M | 13.64M | 138.75M | 233.86M | 117.00M | 110.98M | 1.60M | 1.49M | 1.30M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | -13.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 239.61M | 203.47M | 158.69M | 159.21M | 166.72M | 179.03M | 181.93M | 208.14M | 164.56M | 158.96M | 158.74M | 13.64M | 138.75M | 233.86M | 117.00M | 110.98M | 1.60M | 1.49M | 1.30M | 0.00 | 0.00 |
| Other Expenses | 624.72M | -1.67M | 1.91M | -962.00K | -1.33M | -4.70M | -893.00K | -1.81M | -1.70M | 31.00K | -3.08M | -3.17M | -1.29M | 0.00 | 0.00 | 0.00 | 0.00 | -86.00K | -458.00K | 0.00 | -6.23M | -5.32M |
| Operating Expenses | 624.72M | 612.70M | 546.09M | 492.77M | 517.42M | 498.76M | 492.95M | 503.46M | 513.07M | 418.95M | 396.40M | 379.34M | 196.05M | 303.31M | 257.59M | 243.88M | 242.15M | 131.69M | 125.85M | 208.59M | 333.55M | 337.89M |
| Cost & Expenses | 1.06B | 1.03B | 897.20M | 809.41M | 832.23M | 793.05M | 796.39M | 803.61M | 810.92M | 663.56M | 627.82M | 594.84M | 536.85M | 485.09M | 409.13M | 388.93M | 386.90M | 358.75M | 335.47M | 324.78M | 333.55M | 337.89M |
| Interest Income | 8.72M | 4.83M | 2.37M | 2.02M | 2.10M | 1.11M | 377.00K | 1.10M | 2.01M | 1.95M | 1.61M | 988.00K | 590.00K | 0.00 | 0.00 | 367.00K | 0.00 | 0.00 | 343.00K | 325.00K | 0.00 | 0.00 |
| Interest Expense | 8.88M | 3.69M | 5.98M | 10.72M | 17.80M | 17.79M | 20.31M | 20.15M | 14.61M | 7.76M | 6.91M | 3.43M | 2.71M | 1.61M | 0.00 | 4.41M | 4.40M | 2.75M | 2.74M | 3.19M | 0.00 | 0.00 |
| Depreciation & Amortization | 47.62M | 45.82M | 43.34M | 47.63M | 54.73M | 42.74M | 42.43M | 43.17M | 47.70M | 32.05M | 28.78M | 24.68M | 20.32M | 18.12M | 16.20M | 14.00M | 12.26M | 13.64M | 16.70M | 12.48M | 11.37M | 10.77M |
| EBITDA | 230.65M | 229.20M | 208.43M | 241.73M | 155.10M | 117.77M | 107.36M | 109.48M | 77.69M | 140.72M | 131.27M | 122.66M | 106.53M | 106.97M | 74.49M | 68.52M | 63.91M | 54.54M | 50.02M | 41.24M | 32.58M | 40.82M |
| EBITDA Ratio | 18.50% | 19.22% | 20.39% | 19.42% | 15.95% | 12.87% | 12.48% | 13.84% | 9.49% | 18.47% | 17.12% | 17.64% | 17.10% | 18.67% | 15.94% | 15.52% | 14.57% | 14.26% | 14.73% | 11.27% | 9.18% | 11.09% |
| Operating Income | 184.88M | 179.52M | 167.63M | 185.66M | 97.97M | 64.99M | 58.05M | 69.01M | 34.51M | 109.06M | 104.07M | 98.18M | 86.21M | 87.74M | 58.29M | 54.43M | 51.65M | 39.81M | 32.09M | 28.25M | 26.84M | 36.72M |
| Operating Income Ratio | 14.83% | 14.76% | 15.75% | 19.87% | 10.44% | 7.48% | 6.74% | 7.92% | 4.05% | 14.11% | 14.14% | 14.12% | 13.84% | 15.32% | 12.47% | 12.28% | 11.78% | 9.91% | 8.62% | 8.04% | 7.57% | 9.98% |
| Total Other Income/Expenses | -10.72M | -3.08M | -8.52M | -10.12M | -20.30M | -24.10M | -17.81M | -16.45M | -19.13M | -8.15M | -8.49M | -2.72M | -2.71M | -1.61M | -1.93M | -4.04M | -3.42M | -3.08M | -1.51M | -2.97M | -26.84M | -36.72M |
| Income Before Tax | 174.15M | 176.44M | 159.11M | 175.24M | 77.67M | 40.89M | 40.24M | 52.56M | 15.38M | 100.92M | 95.58M | 95.46M | 83.50M | 86.13M | 56.36M | 50.39M | 48.23M | 37.82M | 30.58M | 25.28M | 0.00 | 0.00 |
| Income Before Tax Ratio | 13.97% | 14.51% | 14.95% | 18.76% | 8.28% | 4.71% | 4.67% | 6.03% | 1.80% | 13.05% | 12.99% | 13.73% | 13.40% | 15.04% | 12.06% | 11.37% | 11.00% | 9.42% | 8.21% | 7.19% | 0.00% | 0.00% |
| Income Tax Expense | 53.52M | 55.65M | 43.61M | 33.77M | 23.44M | 20.37M | 39.24M | 14.99M | 1.94M | 29.14M | 25.73M | 28.11M | 24.97M | 21.79M | 16.73M | 14.02M | 16.32M | 10.19M | 8.50M | 7.65M | -6.34M | -9.74M |
| Net Income | 121.30M | 121.97M | 113.16M | 136.04M | 51.55M | 20.10M | -2.58M | 34.65M | 9.41M | 63.60M | 60.52M | 66.63M | 57.52M | 63.41M | 38.82M | 35.41M | 31.04M | 24.91M | 19.80M | 16.73M | 27.55M | 39.78M |
| Net Income Ratio | 9.73% | 10.03% | 10.64% | 14.56% | 5.49% | 2.31% | -0.30% | 3.97% | 1.10% | 8.23% | 8.22% | 9.58% | 9.23% | 11.07% | 8.30% | 7.99% | 7.08% | 6.20% | 5.32% | 4.76% | 7.76% | 10.81% |
| EPS | 14.38 | 14.44 | 13.40 | 16.12 | 6.11 | 2.39 | -0.31 | 4.11 | 1.12 | 7.54 | 7.18 | 7.91 | 6.83 | 7.32 | 4.48 | 4.11 | 3.60 | 2.91 | 2.33 | 2.01 | 3.16 | 4.57 |
| EPS Diluted | 14.38 | 14.43 | 13.40 | 16.12 | 6.11 | 2.39 | -0.31 | 4.11 | 1.12 | 7.54 | 7.18 | 7.91 | 6.83 | 7.32 | 4.48 | 4.11 | 3.60 | 2.91 | 2.33 | 2.01 | 3.16 | 4.57 |
| Weighted Avg Shares Out | 8.44M | 8.45M | 8.45M | 8.44M | 8.43M | 8.42M | 8.42M | 8.43M | 8.43M | 8.43M | 8.43M | 8.42M | 8.42M | 8.67M | 8.67M | 8.61M | 8.61M | 8.55M | 8.48M | 8.31M | 8.71M | 8.71M |
| Weighted Avg Shares Out (Dil) | 8.44M | 8.45M | 8.45M | 8.44M | 8.43M | 8.42M | 8.42M | 8.43M | 8.43M | 8.43M | 8.43M | 8.42M | 8.42M | 8.67M | 8.67M | 8.61M | 8.61M | 8.55M | 8.48M | 8.31M | 8.71M | 8.71M |
Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.
1 growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the indicator for the previous financial year on the basis of...
Virbac SA (VRBCF) Q2 2024 Earnings Call Transcript
Virbac SA (OTCPK:VRBCF) Q2 2024 Results Conference Call September 16, 2024 8:00 AM ET Company Participants Sandrine Brunel - Head of Corporate Communications Sébastien Huron - Chief Executive Officer Habib Ramdani - Chief Financial Officer Sandrine Brunel Good afternoon. We...
Source: https://incomestatements.info
Category: Stock Reports